Issue Date: November 12, 2012
Pharmaceutical Sales And Earnings Growth Remain In The Doldrums
The pharmaceutical industry more than survived the recession, posting sales and earnings growth annually from 2008 to 2011. This year, though, it is succumbing to a different affliction: A rash of patent expirations has spread throughout the first nine months and put the sector on track to finish 2012 below 2011 levels.
For the third consecutive quarter, no relief came as combined sales and earnings declined at the major pharma companies tracked by C&EN. Overall, . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society